140 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 May 22
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
7:00am
in Refractory Chronic Cough
Session: Session B40 - Assessment and Treatment of Cough and Dyspnea
Date/Time: Monday, May 16, 2022, 2:15-4:15 p.m. ET/11:15-1:15 …
Session: Session B40 - Assessment and Treatment of Cough and Dyspnea
Date/Time: Monday, May 16, 2022, 2:15-4:15 p.m. ET/11:15-1:15 p.m. PT
The three
40-F
2020 FY
BLU
Bellus Health Inc
25 Feb 21
Annual report (Canada)
4:58pm
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over … assessed the effectiveness of The Registrant’s internal control over financial reporting as at December 31, 2020. In making its assessment, management
6-K
EX-99.1
BLU
Bellus Health Inc
10 May 21
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
7:03am
: Assessment and Treatment of Cough and Chronic Dyspnea (TP044)
Format: On demand
Title: Baseline Characteristics and Burden of Disease in Populations Defined … by Cough Frequency Tiers in RELIEF, a Phase 2 Study on the Efficacy and Safety of BLU-5937 in Refractory Chronic Cough
Session: Assessment
40-F
2021 FY
BLU
Bellus Health Inc
23 Feb 22
Annual report (Canada)
5:20pm
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over … assessed the effectiveness of The Registrant’s internal control over financial reporting as at December 31, 2021. In making its assessment, management
F-10
EX-4.3
BLU
Bellus Health Inc
23 Feb 05
Registration of securities (Canada)
12:00am
and director assessment. The current members of the
Nominating and Corporate Governance Committee are Mr. Ronald M. Nordmann
(chair), Dr. Frederick H. Lowy, Mr … . Committee, responsible for the appointment and assessment of directors.
non-management directors, a majority of whom All the members
6-K
ec8ueox1rp95zcfi
20 Apr 05
Current report (foreign)
12:00am
F-10
EX-4.3
owdisn9
3 Sep 19
Registration of securities (Canada)
7:53am
F-10
EX-4.3
osaxpn cs3wt
20 Dec 19
Registration of securities (Canada)
4:03pm
6-K
EX-99.1
0emwx d480xwp3xv
21 Oct 08
Current report (foreign)
12:00am
6-K
awwyr7vx79o
21 Jan 04
Current report (foreign)
12:00am
6-K
tv3zp qsiftphz
9 Dec 03
Current report (foreign)
12:00am
6-K
l8yr gpjfkigq1
22 Jan 04
Current report (foreign)
12:00am
6-K
8pkwxmn
26 Nov 03
Current report (foreign)
12:00am
6-K
hzz 10a4kie
5 Jul 05
Current report (foreign)
12:00am
F-10
EX-4.5
9vjv ds1x2drm5gaz19k
3 Sep 19
Registration of securities (Canada)
7:53am
6-K
df7sl
19 Apr 05
Current report (foreign)
12:00am
6-K
04s9ah5 oel9w
14 Apr 04
Current report (foreign)
12:00am
6-K
6zc vm7ywlhye
1 Feb 07
Current report (foreign)
12:00am
6-K
xrdmjl4zn frdvng
4 Nov 03
Current report (foreign)
12:00am
6-K
EX-99.1
kx8bqq 7tvyyvidw
14 Nov 19
Condensed Consolidated Interim Financial Statements of
3:35pm